[1] |
LIU Jing, WANG Jinquan.
Present and future of therapeutic drugs for diabetic kidney diseases
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2022, 31(5): 470-474.
|
[2] |
YANG Liu, XIE Honglang.
Cardiorenal protective effects and mechanisms of incretinbased therapy
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2022, 31(4): 373-378.
|
[3] |
YANG Liu, XIE Honglang.
Intestinal microenvironment and diabetic kidney disease
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2021, 30(2): 170-174.
|
[4] |
ZHAO Junhua, NIU Jie, ZHOU Ping.
Research progress on intestinal flora and skeletal muscle consumption
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2021, 30(2): 175-179.
|
[5] |
SHI Wen,ZHANG Xiaoliang.
Current status and research updates on treatment of diabetic kidney disease
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2020, 29(4): 375-380.
|
[6] |
TANG Gang,YUAN Weijie.
Re-understanding relationship between intestinal flora and kidney disease from an ecological perspective#br#
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2020, 29(2): 176-180.
|
[7] |
DANG Jianzhong,TU Yafang,WANG Juan, et al.
ARA290 inhibits oxidative stress in kidney of diabetic rats
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2019, 28(5): 435-440.
|
[8] |
WEI Meng,LIANG Shanshan,WANG Meng,et al.
Intestinal barrier dysfunction and relationship with microinflammation in uremic rats#br#
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2019, 28(5): 441-445.
|
[9] |
LI Jing,HAO Chuanming.
Research progress on renal protective effects of prostacyclin
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2018, 27(6): 565-569.
|
[10] |
HUANG Zhihua,YUAN Qiongjing,TANG Wenbin,et al.
Research of Krüppellike factor 4 inhibit inflammation in MES13 cells stimulated by high glucose
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2018, 27(4): 336-341.
|
[11] |
LIU Yang,ZHANG Haitao.
Mechanisms and treatment of obesity related kidney disease
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2018, 27(4): 374-378.
|
[12] |
YU Honglei,YUAN Weijie.
Effect of sodiumglucose cotransporter 2 inhibition in patients with diabetic kidney disease
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2018, 27(2): 174-177.
|
[13] |
XIE Yijun,ZHANG Qian,XUE Yaoming.
microRNA on renal tubular interstitial fibrosis in diabetic nephropathy
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2017, 26(5): 457-462.
|
[14] |
YI Meng,XIE Honglang.
Recent advances in management of diabetic kidney disease
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2016, 25(5): 461-465.
|
[15] |
YANG Shi-kun ,XIAO Li,,LIU Fu-you,et al.
Progress of Clinical and Experimental Research to the new drugs of diabetic kidney disease
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2012, 21(5): 475-479.
|